About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

SUSPENDEDPhase 1NCT00541333

Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

The purpose of the project is to investigate in eyes with dry AMD, the efficacy and safety as preventive therapy of the immunomodulatory substance named copaxone which had been proven as safe and effe...

Lead sponsor: The New York Eye & Ear Infirmary•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

The New York Eye & Ear Infirmary

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Dry AMD in one or both eyes
•2. Age 50 or above of either gender
•3. Signed informed consent.

Exclusion Criteria

•1. Known sensitivity to Mannitol or Copaxone.
•2. Skin disease or active infection of skin.
•3. Active fever or active treatment for infection.
•4. History of other uncontrolled systemic active disease.
•5. Premenopausal females not using reliable birth control.
•6. Sensitivity to fluorescein or iodine.
•7. Inability to comply with study procedures.

Related studies

TERMINATEDPhase 1/2

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

NCT01674829 · Dry Age Related Macular Degeneration

Transcorneal Electrical Stimulation Therapy for Retinal Disease

NCT00804102 · Retinitis Pigmentosa, Macula Off, and more

COMPLETEDPhase 2

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

NCT00429936 · Geographic Atrophy, Dry Age Related Macular Degeneration

COMPLETEDPhase 4

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

NCT00751361 · Dry Age Related Macular Degeneration

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 3, 2013Terms

Trial snapshot

StatusSUSPENDED

PhasePHASE1

Enrollment15

Start dateDec 2007

Last updatedMay 3, 2013

Condition

Dry Age Related Macular Degeneration

Locations shown

New York Eye and Ear Infirmary

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions